Company Summary
Siege Pharmaceuticals is developing new cancer drugs based on a naturally-occurring molecule that starves cancer cells to death. Our drugs are synthetic variants with optimized drug-like properties. By targeting multiple pathways that cancer cells need for growth, it is intended that cancers will be unable to develop resistance, a common challenge with most cancer therapies. The company’s programs are currently at the preclinical stage.